Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis - PubMed
Review
Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis
Sarah L Cudmore et al. Clin Microbiol Rev. 2004 Oct.
Abstract
Infections with the sexually transmitted protozoan Trichomonas vaginalis are usually treated with metronidazole, a 5-nitroimidazole drug derived from the antibiotic azomycin. Metronidazole treatment is generally efficient in eliminating T. vaginalis infection and has a low risk of serious side effects. However, studies have shown that at least 5% of clinical cases of trichomoniasis are caused by parasites resistant to the drug. The lack of approved alternative therapies for T. vaginalis treatment means that higher and sometimes toxic doses of metronidazole are the only option for patients with resistant disease. Clearly, studies of the treatment and prevention of refractory trichomoniasis are essential. This review describes the mechanisms of metronidazole resistance in T. vaginalis and provides a summary of trichomonicidal and vaccine candidate drugs.
Similar articles
-
Seña AC, Bachmann LH, Hobbs MM. Seña AC, et al. Expert Rev Anti Infect Ther. 2014 Jun;12(6):673-85. doi: 10.1586/14787210.2014.887440. Epub 2014 Feb 20. Expert Rev Anti Infect Ther. 2014. PMID: 24555561 Review.
-
Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis.
Dunne RL, Dunn LA, Upcroft P, O'Donoghue PJ, Upcroft JA. Dunne RL, et al. Cell Res. 2003 Aug;13(4):239-49. doi: 10.1038/sj.cr.7290169. Cell Res. 2003. PMID: 12974614 Review.
-
Hager WD. Hager WD. Sex Transm Dis. 2004 Jun;31(6):343-5. doi: 10.1097/00007435-200406000-00004. Sex Transm Dis. 2004. PMID: 15167642
-
A case of metronidazole-resistant Trichomonas vaginalis in pregnancy.
Forbes GL, Drayton R, Forbes GD. Forbes GL, et al. Int J STD AIDS. 2016 Sep;27(10):906-8. doi: 10.1177/0956462415601295. Epub 2015 Sep 18. Int J STD AIDS. 2016. PMID: 26384945
-
Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative.
Bitencourt FG, de Brum Vieira P, Meirelles LC, Rigo GV, da Silva EF, Gnoatto SCB, Tasca T. Bitencourt FG, et al. Parasitol Res. 2018 May;117(5):1573-1580. doi: 10.1007/s00436-018-5839-1. Epub 2018 Mar 23. Parasitol Res. 2018. PMID: 29572567
Cited by
-
Martínez-Díaz RA, Ibáñez-Escribano A, Burillo J, Heras Lde L, Prado GD, Agulló-Ortuño MT, Julio LF, González-Coloma A. Martínez-Díaz RA, et al. Mem Inst Oswaldo Cruz. 2015 Aug;110(5):693-9. doi: 10.1590/0074-02760140129. Epub 2015 Jun 24. Mem Inst Oswaldo Cruz. 2015. PMID: 26107187 Free PMC article.
-
Kumar S, Bains T, Won Kim AS, Tam C, Kim J, Cheng LW, Land KM, Debnath A, Kumar V. Kumar S, et al. Front Cell Infect Microbiol. 2018 Oct 30;8:380. doi: 10.3389/fcimb.2018.00380. eCollection 2018. Front Cell Infect Microbiol. 2018. PMID: 30425970 Free PMC article.
-
Kucknoor A, Mundodi V, Alderete JF. Kucknoor A, et al. Cell Microbiol. 2005 Jun;7(6):887-97. doi: 10.1111/j.1462-5822.2005.00522.x. Cell Microbiol. 2005. PMID: 15888089 Free PMC article.
-
Fang L, Lu X, Cui C, Shi Q, Wang H. Fang L, et al. Am J Transl Res. 2022 Jun 15;14(6):4015-4023. eCollection 2022. Am J Transl Res. 2022. PMID: 35836901 Free PMC article.
-
Gaona-López C, Vazquez-Jimenez LK, Gonzalez-Gonzalez A, Delgado-Maldonado T, Ortiz-Pérez E, Nogueda-Torres B, Moreno-Rodríguez A, Vázquez K, Saavedra E, Rivera G. Gaona-López C, et al. Pharmaceuticals (Basel). 2023 Apr 4;16(4):543. doi: 10.3390/ph16040543. Pharmaceuticals (Basel). 2023. PMID: 37111300 Free PMC article. Review.
References
-
- Aburel, E., G. Zervos, V. Titea, and S. Pana. 1963. Immunological and therapeutic investigations in vaginal trichomoniasis. Rom. Med. Rev. 7:13-19. - PubMed
-
- Adugu, I. S., D. Nolder, D. S. Warhurst, and J. F. Rossignol. 2002. In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis. Entamoeba histolytica, and Trichomonas vaginalis. J. Antimicrob. Chemother. 49:103-111. - PubMed
-
- Ackers, J. P. 1990. Immunologic aspects of human trichomoniasis, p. 36-52. In B. M. Honigberg (ed.), Trichomonads parasitic in humans. Springer-Verlag, New York, N.Y.
-
- Addis, M. A., P. Rappelli, A. M. P. de Andrade, F. M. Rita, M. M. Colombo, P. Cappuccinelli, and P. L. Fiori. 1999. Identification of Trichomonas vaginalis α-actinin as the most common immunogen recognized by the sera of women exposed to the parasite. J. Infect. Dis. 180:1727-1730. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical